|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Fees and other receivables | ||||||||||||||||||||
| OEIC and unit trust receivables | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||
| Property, equipment and software, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Retirement benefit asset, net | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Consolidated Entity, Excluding Consolidated VIE | ||||||||||||||||||||
| Total accounts payable and accrued liabilities | ||||||||||||||||||||
| Current portion of accrued compensation, benefits and staff costs | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| OEIC and unit trust payables | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities: | ||||||||||||||||||||
| Accrued compensation, benefits and staff costs | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Retirement benefit obligations, net | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| REDEEMABLE NONCONTROLLING INTERESTS | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Common stock, $1.50 par value; 480,000,000 shares authorized, 154,075,608 and 154,075,608 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury shares, 42,327 and 46,306 shares held at March 31, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of tax | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Nonredeemable noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interests and equity | ||||||||||||||||||||
Loading...
